Dextroamphetamine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{DrugProjectFormSinglePage
{{DrugProjectFormSinglePage
|authorTag=<!--Overview-->
|authorTag={{
|aOrAn=a
|aOrAn=a
|hasBlackBoxWarning=Yes
|hasBlackBoxWarning=Yes

Revision as of 18:36, 12 December 2014

{{DrugProjectFormSinglePage |authorTag={{ |aOrAn=a |hasBlackBoxWarning=Yes |adverseReactions= |blackBoxWarningTitle=ConditionName: |blackBoxWarningBody=ConditionName:

  • Content


|fdaLIADAdult======Condition1=====

  • Dosing Information
  • Dosage
Condition2
  • Dosing Information
  • Dosage
Condition3
  • Dosing Information
  • Dosage
Condition4
  • Dosing Information
  • Dosage


|offLabelAdultGuideSupport======Condition1=====

  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Dextroamphetamine in adult patients.

|offLabelAdultNoGuideSupport======Condition1=====

  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dextroamphetamine in adult patients.


|fdaLIADPed======Condition1=====

  • Dosing Information
  • Dosage
Condition2

There is limited information regarding FDA-Labeled Use of Dextroamphetamine in pediatric patients.


|offLabelPedGuideSupport======Condition1=====

  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Dextroamphetamine in pediatric patients.

|offLabelPedNoGuideSupport======Condition1=====

  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dextroamphetamine in pediatric patients.

|contraindications=* Condition1

|warnings=* Description

Precautions

  • Description


|clinicalTrials=There is limited information regarding Clinical Trial Experience of Dextroamphetamine in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

|postmarketing=There is limited information regarding Postmarketing Experience of Dextroamphetamine in the drug label.

Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous

|drugInteractions=* Drug

  • Description

|useInPregnancyFDA=* Pregnancy Category |useInPregnancyAUS=* Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Dextroamphetamine in women who are pregnant. |useInLaborDelivery=There is no FDA guidance on use of Dextroamphetamine during labor and delivery. |useInNursing=There is no FDA guidance on the use of Dextroamphetamine with respect to nursing mothers. |useInPed=There is no FDA guidance on the use of Dextroamphetamine with respect to pediatric patients. |useInGeri=There is no FDA guidance on the use of Dextroamphetamine with respect to geriatric patients. |useInGender=There is no FDA guidance on the use of Dextroamphetamine with respect to specific gender populations. |useInRace=There is no FDA guidance on the use of Dextroamphetamine with respect to specific racial populations. |useInRenalImpair=There is no FDA guidance on the use of Dextroamphetamine in patients with renal impairment. |useInHepaticImpair=There is no FDA guidance on the use of Dextroamphetamine in patients with hepatic impairment. |useInReproPotential=There is no FDA guidance on the use of Dextroamphetamine in women of reproductive potentials and males. |useInImmunocomp=There is no FDA guidance one the use of Dextroamphetamine in patients who are immunocompromised.

|administration=* Oral

  • Intravenous

|monitoring=There is limited information regarding Monitoring of Dextroamphetamine in the drug label.

  • Description

|IVCompat=There is limited information regarding IV Compatibility of Dextroamphetamine in the drug label.

|overdose====Acute Overdose===

Signs and Symptoms

  • Description

Management

  • Description

Chronic Overdose

There is limited information regarding Chronic Overdose of Dextroamphetamine in the drug label.


|drugBox= |mechAction=*

|structure=*

File:Dextroamphetamine01.png
This image is provided by the National Library of Medicine.

|PD=There is limited information regarding Pharmacodynamics of Dextroamphetamine in the drug label.

|PK=There is limited information regarding Pharmacokinetics of Dextroamphetamine in the drug label.

|nonClinToxic=There is limited information regarding Nonclinical Toxicology of Dextroamphetamine in the drug label.

|clinicalStudies=There is limited information regarding Clinical Studies of Dextroamphetamine in the drug label.

|howSupplied=*

|fdaPatientInfo=There is limited information regarding Patient Counseling Information of Dextroamphetamine in the drug label.

|alcohol=* Alcohol-Dextroamphetamine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

|brandNames=* ®[1]

|lookAlike=* A® — B®[2]

|drugShortage= }} {{#subobject:

 |Page Name=Dextroamphetamine
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Dextroamphetamine
 |Label Name=Dextroamphetamine11.png

}}

{{#subobject:

 |Label Page=Dextroamphetamine
 |Label Name=Dextroamphetamine11.png

}}

  1. Empty citation (help)
  2. "http://www.ismp.org". External link in |title= (help)